Optimal antithrombotic management after intracerebral hemorrhage remains one of the
central unresolved issues for patients who survive, especially for those patients with atrial …

Opinion statement Anticoagulation is a vital therapy in a number of different disease
processes, and is strongly recommended for the prevention of stroke in patients with atrial …

Background In patients with atrial fibrillation (AF) who survive an anticoagulant-related
intracranial hemorrhage (ICH), the benefits of restarting oral anticoagulation (OAC) remain …

Background—Intracranial hemorrhage is the most feared complication of oral anticoagulant
treatment. The optimal treatment option for patients with atrial fibrillation who survive an …

Background We summarize the existing evidence on the potential benefit of oral
anticoagulation (OAC) in intracerebral hemorrhage (ICH) survivors with nonvalvular atrial …

The aim of this survey is to provide a snapshot of current practice regarding antithrombotic
therapy (ATT) in patients with atrial fibrillation (AF) comorbid with intracerebral haemorrhage …

Intracranial haemorrhage (ICH), which affects up to 1% of patients on oral anticoagulation
per year, is the most feared and devastating complication of this treatment. After such an …

Background To investigate the effectiveness and safety of withholding or restarting
antithrombotic agents, and different antithrombotic therapies among patients with atrial …

Background While oral anticoagulants (OACs) are highly effective for ischemic stroke
prevention in atrial fibrillation, intracerebral hemorrhage (ICH) remains the most feared …

Decisions regarding resumption of anticoagulation are difficult in patients who present with a
warfarin-associated intracranial hemorrhage and also have atrial fibrillation or a prosthetic …